Please login to the form below

Not currently logged in
Email:
Password:

Israel

This page shows the latest Israel news and features for those working in and with pharma, biotech and healthcare.

Gilead study resurrects HIV eradication hope

Gilead study resurrects HIV eradication hope

the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, where the research was carried out.

Latest news

  • A unique ecosystem A unique ecosystem

    workshop in Israel. ... In 2018, Medicen will continue its international dynamics with a long-term perspective towards the main ecosystems it already addresses: the US, Canada, Europe, Israel and Japan.

  • Teva cuts 25% of workforce, with Israel taking a heavy toll Teva cuts 25% of workforce, with Israel taking a heavy toll

    Israel’s biggest trade union Histadrut has already threatened strike action to protest the cutbacks. ... In a letter to Israeli prime minister Benjamin Netanyahu, the new CEO insists that the measures are necessary to “preserve Teva as a strong

  • Sanofi/Regeneron start first filings for PD-1 drug cemiplimab Sanofi/Regeneron start first filings for PD-1 drug cemiplimab

    Advanced CSCC is responsible for 3, 900 to 8, 800 deaths per year in the US, ”said Regeneron’s clinical development head Israel Lowy.

  • Teva sheds R&D chief after new CEO takes the helm Teva sheds R&D chief after new CEO takes the helm

    All three will retire at the end of the year. Another 4, 000 positions are set to be cut from Teva’s headquarters and other facilities within Israel - something that prior ... Teva employs around 7, 000 people in Israel, with thousands more working in

  • Mitsubishi buys Israel's NeuroDerm for $1.1bn Mitsubishi buys Israel's NeuroDerm for $1.1bn

    Mitsubishi buys Israel's NeuroDerm for $1.1bn. The deal will see it focus on a series of drug-device combinations for Parkinson’s disease, headed by phase III candidate ND0612.

More from news
Approximately 3 fully matching, plus 126 partially matching documents found.

Latest Intelligence

  • A unique ecosystem A unique ecosystem

    workshop in Israel. ... In 2018, Medicen will continue its international dynamics with a long-term perspective towards the main ecosystems it already addresses: the US, Canada, Europe, Israel and Japan.

  • Pharma deals continue to slide Pharma deals continue to slide

    The main manufacturing operation is in Israel with supporting operations in India and the US. ... Perrigo API (US). SK Capital (US). Asset acquisition. API manufacturing operations primarily in Israel with supporting units in US and India.

  • Taking a lean and careful approach Taking a lean and careful approach

    Clinical trials. The company is moving cautiously and set its clinical trials in Israel, Italy, Turkey and Greece.

  • European sites European sites

    Key findings. In total there are roughly 11, 000 life science companies (biotech, pharma, medtech) across 14 European countries and in Israel.

  • Forging a path in specialty care Forging a path in specialty care

    Around the world they've launched in a number of new markets, including Israel, which comes under Princen's remit … a strange geographical choice. “ ... Israel is a very innovative country with a lot of people with ideas, so it is much closer to

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Competition from within

    Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy - which have since merged - the only representation from the ‘ BRIC’ markets (Brazil,

  • Do you speak Human?

    A recent white paper published by Quintiles stated that, while the MENA region (excluding Israel) currently hosts only about 0.4% of clinical trial sites and patients, its percentage of global

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics